X4 Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: XFORHealthcare
Live X4 Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
X4 Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$2.85Low
$2.96High
Markets Today
| Previous Close | $2.79 |
|---|---|
| Open | $2.85 |
| Volume | 540,494 |
| Day's Range | $2.85 - $2.96 |
| 52W Range | $2.70 - $4.83 |
| Market Cap | $276.62 M |
Historical Performance
| 1M Returns | -14.41 |
|---|---|
| 3M Returns | -34.01 |
| 6M Returns | -29.02 |
| 1Y Returns | -5.83 |
| 5Y Returns | -98.17 |
| 10Y Returns | NA |
X4 Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $276.62 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $35.11 M |
| ROE TTM | -0.76 |
| EPS TTM | $-1.24 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.73 |
| EBITDA | $-85.61 M |
| Profit Margin | -225.55 |
| Market Cap | $276.62 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $35.11 M |
| ROE TTM | -0.76 |
| EPS TTM | $-1.24 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.73 |
| EBITDA | $-85.61 M |
| Profit Margin | -225.55 |
X4 Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $28.81 M | $1.97 M | $1.76 M | $2.57 M | $2.71 M | $8.81 M |
| Gross Profit + | $24.09 M | $1.65 M | $1.41 M | $2.20 M | $2.11 M | $7.19 M |
| Operating Income | -$9.44 M | -$26.23 M | -$27.51 M | -$23.70 M | -$20.31 M | -$16.39 M |
| EBITDA | -$8.97 M | -$25.88 M | -$27.29 M | -$23.48 M | -$20.08 M | -$15.39 M |
| Interest Expense | -$2.20 M | -$2.23 M | -$2.26 M | -$2.19 M | -$2.13 M | -$2.16 M |
| Depreciation | $476.00 K | $355.00 K | $223.00 K | $223.00 K | $223.00 K | $997.00 K |
| Income Before Tax | $316.00 K | -$25.70 M | -$29.84 M | -$23.93 M | -$20.24 M | -$16.16 M |
| Income Tax Expense | $34.00 K | $37.00 K | -$30.00 K | $0 | $0 | $2.00 K |
| Net Income + | $282.00 K | -$25.74 M | -$29.82 M | -$23.93 M | -$20.24 M | -$16.16 M |
| Net Profit Margin | 0.98% | -1304.66% | -1689.24% | -931.66% | -747.45% | -183.48% |
X4 Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $6.00 K | $8.00 K | $25.00 K | $91.00 K | $94.00 K | $96.00 K |
| Reserve & Surplus | -$515.20 M | -$540.95 M | -$570.75 M | -$594.66 M | -$614.92 M | -$631.08 M |
| Non-Current Liabilities | $81.19 M | $78.30 M | $78.43 M | $78.41 M | $78.06 M | $78.24 M |
| Current Liabilities | $25.88 M | $22.90 M | $23.51 M | $25.76 M | $23.77 M | $19.37 M |
| Total Liabilities | $107.07 M | $101.20 M | $101.94 M | $104.17 M | $101.83 M | $97.61 M |
| Fixed Assets | $10.30 M | $9.88 M | $9.66 M | $9.43 M | $9.21 M | $13.21 M |
| Current Assets | $95.70 M | $72.94 M | $132.81 M | $261.58 M | $241.98 M | $218.85 M |
| Total Assets | $130.01 M | $105.17 M | $163.56 M | $290.46 M | $270.28 M | $253.06 M |
X4 Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $282.00 K | -$25.74 M | -$29.82 M | -$23.93 M | -$20.24 M | -$16.16 M |
| Operating Cash Flow | -$12.37 M | -$29.90 M | -$27.82 M | -$15.53 M | -$19.60 M | -$20.79 M |
| Investing Cash Flow | -$3.14 M | $23.11 M | -$28.67 M | $16.85 M | $19.25 M | -$1.00 M |
| Financing Cash Flow | $0 | $5.63 M | $86.91 M | $146.09 M | $2.00 K | $75.00 K |
| Change in Cash | -$15.43 M | -$1.02 M | $30.41 M | $147.42 M | -$365.00 K | -$21.72 M |
X4 Pharmaceuticals, Inc. Common Stock Return Calculator
The X4 Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$177
Invested Amount$10,000
Est. Returns$-9,823
About X4 Pharmaceuticals, Inc. Common Stock
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Popular Stocks
FAQs
What is the share price of X4 Pharmaceuticals, Inc. Common Stock today?
X4 Pharmaceuticals, Inc. Common Stock (XFOR) share price as of October 10, 2026 is $2.82. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of X4 Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the X4 Pharmaceuticals, Inc. Common Stock (XFOR) Share by opening an international trading account with Angel One.
How can I purchase X4 Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing X4 Pharmaceuticals, Inc. Common Stock (XFOR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying X4 Pharmaceuticals, Inc. Common Stock (XFOR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of X4 Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of X4 Pharmaceuticals, Inc. Common Stock (XFOR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of X4 Pharmaceuticals, Inc. Common Stock?
The market capitalization of X4 Pharmaceuticals, Inc. Common Stock on October 10, 2026, is $276.62 M.
In which sector X4 Pharmaceuticals, Inc. Common Stock belongs?
X4 Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in X4 Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in X4 Pharmaceuticals, Inc. Common Stock (XFOR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
